Interventions to Improve COVID-19 Vaccine Hesitancy

IF 2.6 4区医学 Q2 RHEUMATOLOGY Rheumatic Disease Clinics of North America Pub Date : 2024-10-11 DOI:10.1016/j.rdc.2024.09.007

Nnenna Ezeh MD, MPH , Taussia Boadi BA , Maria I. Danila MD, MSc, MSPH , Rosalind Ramsey-Goldman MD, MPH, DrPH , Candace H. Feldman MD, MPH, ScD

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

改善 COVID-19 疫苗犹豫不决的干预措施。

尽管相关不良后果的风险增加，但风湿病患者对 2019 年冠状病毒病（COVID-19）疫苗的接种率仍然很低。这种情况在历史上被边缘化的人群中尤为明显，他们在 COVID-19 大流行中遭受的伤害尤为严重。在疫苗接种率低的众多原因中，对医疗保健系统的不信任、与疫苗开发过程相关的错误信息、对风湿病复发的恐惧以及医生建议的不一致都是突出的原因。目前正在进行两项随机对照试验，利用多模式策略和社区合作来传播 COVID-19 疫苗信息，减少犹豫，并希望提高疫苗的接种率，尤其是在边缘化社区。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Rheumatic Disease Clinics of North America 医学-风湿病学

CiteScore

4.20

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Rheumatic Disease Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue (February, May, August, and November) focuses on a single topic in rheumatology and is presented under the direction of an experienced editor. Topics include osteoarthritis, rheumatoid arthritis, crystal diseases, MSK exam, disorders of the bone, immunodeficiency states, lupus, neuromuscular disease, pain disorders, scleroderma, vasculitis, pediatrics, therapeutics, treatment guidelines, and treatment modalities.

期刊最新文献

Contents Coronavirus Disease-2019 in the Immunocompromised Host Review of Immunologic Manifestations of COVID-19 Infection and Vaccination SARS-CoV-2 Infection and COVID-19 in Children The Short and Long of COVID-19